Brown Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,843,960
| Closed | -$26.5M | – | 118 |
|
|
2024
Q4 | $26.5M | Sell |
1,843,960
-351,359
| -16% | -$5.05M | 0.61% | 42 |
|
|
2024
Q3 | $49.6M | Sell |
2,195,319
-288,386
| -12% | -$6.51M | 1.07% | 33 |
|
|
2024
Q2 | $48.3M | Sell |
2,483,705
-191,142
| -7% | -$3.72M | 0.98% | 32 |
|
|
2024
Q1 | $100M | Sell |
2,674,847
-852,450
| -24% | -$32M | 1.78% | 21 |
|
|
2023
Q4 | $197M | Buy |
3,527,297
+446,192
| +14% | +$25M | 2.96% | 18 |
|
|
2023
Q3 | $127M | Buy |
3,081,105
+3,524
| +0.1% | +$145K | 1.95% | 20 |
|
|
2023
Q2 | $172M | Buy |
3,077,581
+1,992
| +0.1% | +$111K | 2.44% | 18 |
|
|
2023
Q1 | $172M | Buy |
3,075,589
+1,621,959
| +112% | +$90.5M | 2.56% | 17 |
|
|
2022
Q4 | $53M | Sell |
1,453,630
-161,463
| -10% | -$5.88M | 0.88% | 31 |
|
|
2022
Q3 | $46M | Sell |
1,615,093
-815,862
| -34% | -$23.2M | 0.64% | 37 |
|
|
2022
Q2 | $110M | Buy |
2,430,955
+767,486
| +46% | +$34.7M | 1.47% | 27 |
|
|
2022
Q1 | $127M | Buy |
1,663,469
+410,340
| +33% | +$31.2M | 1.26% | 29 |
|
|
2021
Q4 | $187M | Sell |
1,253,129
-8,042
| -0.6% | -$1.2M | 1.54% | 23 |
|
|
2021
Q3 | $184M | Buy |
1,261,171
+32,486
| +3% | +$4.73M | 1.5% | 25 |
|
|
2021
Q2 | $241M | Buy |
1,228,685
+550,344
| +81% | +$108M | 1.82% | 22 |
|
|
2021
Q1 | $123M | Buy |
678,341
+220,100
| +48% | +$39.8M | 0.91% | 34 |
|
|
2020
Q4 | $64.9M | Buy |
+458,241
| New | +$64.9M | 0.45% | 40 |
|